An analysis conducted by Friends of Cancer Research showed that the FDA Breakthrough Therapy Designation criteria select drugs that lead to better outcomes for patients with lung cancer.
A committee of the European Medicines Agency recommended the approval for expanded use of Keytruda (pembrolizumab) as a standalone therapy for the adjuvant treatment of adults and adolescents aged 12 years and older with stage IIB or IIC melanoma who have undergone complete resection.
Case Western Reserve University signed an exclusive license agreement with Picture Health to develop AI technologies to help predict, diagnose, and treat lung cancer.
AmerisourceBergen launched Clinical Trial Navigator, a solution suite that supports biopharmaceutical clinical trial recruitment within community-based specialty practices.
Fox Chase Cancer Center used to be a place where Nobel laureates toiled. Now, people who love the place—and in oncology, many people do—are hoping that Jonathan Chernoff, Fox Chase’s new director, will restore vitality to the venerable Philadelphia-based cancer center.
Hospitals and radiology clinics are rationing—of all things—intravenous contrast agents used for computed tomography imaging.
The Union for International Cancer Control and multiple partners are establishing the Access to Oncology Medicines Coalition, a global partnership to increase access to quality-assured essential cancer medicines in low- and lower-middle-income countries, and to help countries develop the capacity for their proper use.
The Committee on Energy and Commerce passed a bill May 18 that would authorize the establishment of the Advanced Research Project Agency for Health as an independent agency within HHS.
ASCO and the Association of Community Cancer Centers jointly released recommendations addressing the lack of equity, diversity, and inclusion in cancer clinical trials.
Vetta Sanders Thompson was named the inaugural associate director of diversity, equity, and inclusion at Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital.
